Cross-Sectional and Longitudinal Associations of Comorbidities with Knee Symptoms and Radiographic Abnormalities of Osteoarthritis.

Comorbidity Disability Osteoarthritis Pain Radiographic OA

Journal

Rheumatology and therapy
ISSN: 2198-6576
Titre abrégé: Rheumatol Ther
Pays: England
ID NLM: 101674543

Informations de publication

Date de publication:
18 Nov 2023
Historique:
received: 02 08 2023
accepted: 27 10 2023
medline: 19 11 2023
pubmed: 19 11 2023
entrez: 18 11 2023
Statut: aheadofprint

Résumé

This study aimed to investigate the associations of comorbidities with knee symptoms and radiographic abnormalities of osteoarthritis (OA). Participants were from the Osteoarthritis Initiative. Comorbidities were identified at baseline using the modified Charlson Comorbidity Index. For both knees, symptoms were assessed annually from baseline to 48 months using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain and function scores (rescaled range 0-100), and radiographic abnormalities using the Kellgren-Lawrence (KL, 0-4) grades. The presence of significant pain and functional disability was defined as a WOMAC score of ≥ 25 and ≥ 22, respectively, and radiographic OA (ROA) as KL ≥ 2. An increase of ≥ 9 in WOMAC scores and ≥ 1 in KL grades were defined as symptomatic and radiographic progression, respectively. Of 3337 participants, 28% and 9% had one and ≥ 2 comorbidities, respectively. The number of comorbidities was associated with the presence of significant functional disability (odds ratios [ORs] 1.15; 1.46) and predicted the progression of both knee pain and functional disability (ORs 1.11; 1.51). For the type of comorbidities, non-OA musculoskeletal diseases were associated with the presence of ROA and significant functional disability (ORs 1.63; 1.82) and showed a trend to predict incident ROA (OR 1.84, 95% confidence interval 1.00-3.38 p = 0.051). Diabetes and kidney diseases were associated with symptomatic progression of OA (ORs 1.38; 2.72). Having more comorbidities, especially diabetes and kidney diseases, is associated with symptomatic progression of knee OA. Moreover, non-OA musculoskeletal diseases may be associated with the presence and onset of ROA.

Identifiants

pubmed: 37980309
doi: 10.1007/s40744-023-00625-2
pii: 10.1007/s40744-023-00625-2
doi:

Types de publication

Journal Article

Langues

eng

Informations de copyright

© 2023. The Author(s).

Références

Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163–96.
pubmed: 23245607 pmcid: 6350784 doi: 10.1016/S0140-6736(12)61729-2
Chan KW, Ngai HY, Ip KK, Lam KH, Lai WW. Co-morbidities of patients with knee osteoarthritis. Hong Kong Med J. 2009;15(3):168–72.
pubmed: 19494370
Kadam UT, Croft PR. Clinical comorbidity in osteoarthritis: associations with physical function in older patients in family practice. J Rheumatol. 2007;34(9):1899–904.
pubmed: 17659751
Van den Akker MBF, Knottnerus JA. Comorbidity or multimorbidity. Eur J Gen Pract. 1996. https://doi.org/10.3109/13814789609162146 .
doi: 10.3109/13814789609162146
Zemedikun DT, Lee H, Nirantharakumar K, et al. Comorbidity phenotypes and risk of mortality in patients with osteoarthritis in the UK: a latent class analysis. Arthritis Res Ther. 2022;24(1):231.
pubmed: 36229868 pmcid: 9559033 doi: 10.1186/s13075-022-02909-4
Uk AR. Musculoskeletal conditions and multimorbidities report. 2018.
Wesseling J, Welsing PM, Bierma-Zeinstra SM, et al. Impact of self-reported comorbidity on physical and mental health status in early symptomatic osteoarthritis: the CHECK (Cohort Hip and Cohort Knee) study. Rheumatol (Oxf). 2013;52(1):180–8.
doi: 10.1093/rheumatology/kes288
Calders P, Van Ginckel A. Presence of comorbidities and prognosis of clinical symptoms in knee and/or hip osteoarthritis: a systematic review and meta-analysis. Semin Arthritis Rheum. 2018;47(6):805–13.
pubmed: 29157670 doi: 10.1016/j.semarthrit.2017.10.016
Hindy G, Åkesson KE, Melander O, et al. Cardiometabolic polygenic risk scores and osteoarthritis outcomes: a mendelian randomization study using data from the Malmö diet and cancer study and the UK biobank. Arthritis Rheumatol. 2019;71(6):925–34.
pubmed: 30615301 pmcid: 6563114 doi: 10.1002/art.40812
Roubille C, Coste J, Sellam J, Rat AC, Guillemin F, Roux CH. Association of baseline cardiovascular diseases with 5-year knee and hip osteoarthritis progression in non-obese patients: data from the KHOALA cohort. J Clin Med. 2021;10(15):3353.
pubmed: 34362134 pmcid: 8348958 doi: 10.3390/jcm10153353
Eymard F, Parsons C, Edwards MH, et al. Diabetes is a risk factor for knee osteoarthritis progression. Osteoarth Cartilage. 2015;23(6):851–9.
doi: 10.1016/j.joca.2015.01.013
Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care. 1996;34(1):73–84.
pubmed: 8551813 doi: 10.1097/00005650-199601000-00006
Chaturvedi S. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (JNC 7): is it really practical? Natl Med J India. 2004;17(4):227.
pubmed: 15372777
Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833–40 (PMID: 3068365).
pubmed: 3068365
N B. WOMAC Osteoarthritis index user guide. Version V. Brisbane.
Cai G, Li X, Zhang Y, et al. Knee symptom but not radiographic knee osteoarthritis increases the risk of falls and fractures: results from the Osteoarthritis Initiative. Osteoarthr Cartil. 2022;30(3):436–42.
doi: 10.1016/j.joca.2021.11.015
Culvenor AG, Wirth W, Roth M, Hunter DJ, Eckstein F. Predictive capacity of thigh muscle strength in symptomatic and/or radiographic knee osteoarthritis progression: data from the foundation for the national institutes of health osteoarthritis biomarkers consortium. Am J Phys Med Rehabil. 2016;95(12):931–8.
pubmed: 27175558 pmcid: 5107162 doi: 10.1097/PHM.0000000000000534
Eckstein F, Collins JE, Nevitt MC, et al. Brief report: cartilage thickness change as an imaging biomarker of knee osteoarthritis progression: data from the foundation for the national institutes of health osteoarthritis biomarkers consortium. Arthritis Rheumatol. 2015;67(12):3184–9.
pubmed: 26316262 pmcid: 5495918 doi: 10.1002/art.39324
Hunter D, Nevitt M, Lynch J, et al. Longitudinal validation of periarticular bone area and 3D shape as biomarkers for knee OA progression? Data from the FNIH OA Biomarkers Consortium. Ann Rheum Dis. 2016;75(9):1607–14.
pubmed: 26483253 doi: 10.1136/annrheumdis-2015-207602
Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16(4):494–502.
pubmed: 13498604 pmcid: 1006995 doi: 10.1136/ard.16.4.494
Eyler AA, Brownson RC, Bacak SJ, Housemann RA. The epidemiology of walking for physical activity in the United States. Med Sci Sports Exerc. 2003;35(9):1529–36.
pubmed: 12972873 doi: 10.1249/01.MSS.0000084622.39122.0C
Felson DT, Niu J, Guermazi A, et al. Correlation of the development of knee pain with enlarging bone marrow lesions on magnetic resonance imaging. Arthritis Rheum. 2007;56(9):2986–92.
pubmed: 17763427 doi: 10.1002/art.22851
Guccione AA, Felson DT, Anderson JJ. Defining arthritis and measuring functional status in elders: methodological issues in the study of disease and physical disability. Am J Public Health. 1990;80(8):945–9.
pubmed: 2368855 pmcid: 1404793 doi: 10.2105/AJPH.80.8.945
Jordan J, Luta G, Renner J, Dragomir A, Hochberg M, Fryer J. Knee pain and knee osteoarthritis severity in self-reported task specific disability: the Johnston County Osteoarthritis Project. J Rheumatol. 1997;24(7):1344–9.
pubmed: 9228135
Penninx BW, Guralnik JM, Ferrucci L, Simonsick EM, Deeg DJ, Wallace RB. Depressive symptoms and physical decline in community-dwelling older persons. JAMA. 1998;279(21):1720–6.
pubmed: 9624025 doi: 10.1001/jama.279.21.1720
Poulsen E, Goncalves GH, Bricca A, Roos EM, Thorlund JB, Juhl CB. Knee osteoarthritis risk is increased 4–6 fold after knee injury—a systematic review and meta-analysis. Br J Sports Med. 2019;53(23):1454–63.
pubmed: 31072840 doi: 10.1136/bjsports-2018-100022
Sharma L, Cahue S, Song J, Hayes K, Pai YC, Dunlop D. Physical functioning over 3 years in knee osteoarthritis: role of psychosocial, local mechanical, and neuromuscular factors. Arthritis Rheum. 2003;48(12):3359–70.
pubmed: 14673987 doi: 10.1002/art.11420
Jeong H, Baek SY, Kim SW, et al. Comorbidities and health-related quality of life in Koreans with knee osteoarthritis: data from the Korean National Health and Nutrition Examination Survey (KNHANES). PLoS ONE. 2017;12(10): e0186141.
pubmed: 29045425 pmcid: 5646822 doi: 10.1371/journal.pone.0186141
Zorn CJ. Generalized estimating equation models for correlated data: a review with applications. Am J Polit Sci. 2001;45:470–90.
doi: 10.2307/2669353
Lee YH, Tsou HK, Kao SL, et al. Patients with rheumatoid arthritis increased risk of developing osteoarthritis: a nationwide population-based cohort study in Taiwan. Front Med (Lausanne). 2020;7:392.
pubmed: 33015077 doi: 10.3389/fmed.2020.00392
Robinson WH, Lepus CM, Wang Q, et al. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12(10):580–92.
pubmed: 27539668 pmcid: 5500215 doi: 10.1038/nrrheum.2016.136
Kadam UT, Jordan K, Croft PR. Clinical comorbidity in patients with osteoarthritis: a case-control study of general practice consulters in England and Wales. Ann Rheum Dis. 2004;63(4):408–14.
pubmed: 15020335 pmcid: 1754944 doi: 10.1136/ard.2003.007526
Gabriel SE, Crowson CS, O’Fallon WM. Comorbidity in arthritis. J Rheumatol. 1999;26(11):2475–9.
pubmed: 10555912
Ettinger WH Jr, Fried LP, Harris T, Shemanski L, Schulz R, Robbins J. Self-reported causes of physical disability in older people: the Cardiovascular Health Study. CHS collaborative research group. J Am Geriatr Soc. 1994;42(10):1035–44.
pubmed: 7930326 doi: 10.1111/j.1532-5415.1994.tb06206.x
Eitner A, Culvenor AG, Wirth W, Schaible HG, Eckstein F. Impact of diabetes mellitus on knee osteoarthritis pain and physical and mental status: data from the osteoarthritis initiative. Arthritis Care Res (Hoboken). 2021;73(4):540–8.
pubmed: 32105401 doi: 10.1002/acr.24173
Gregg EW, Mangione CM, Cauley JA, et al. Diabetes and incidence of functional disability in older women. Diabetes Care. 2002;25(1):61–7.
pubmed: 11772902 doi: 10.2337/diacare.25.1.61
Eitner A, Pester J, Vogel F, et al. Pain sensation in human osteoarthritic knee joints is strongly enhanced by diabetes mellitus. Pain. 2017;158(9):1743–53.
pubmed: 28621703 doi: 10.1097/j.pain.0000000000000972
Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial. JAMA. 1998;280(17):1490–6.
pubmed: 9809729 doi: 10.1001/jama.280.17.1490
Sinclair AJ, Abdelhafiz AH, Rodríguez-Mañas L. Frailty and sarcopenia - newly emerging and high impact complications of diabetes. J Diabetes Complicat. 2017;31(9):1465–73.
doi: 10.1016/j.jdiacomp.2017.05.003
Lambourg E, Colvin L, Guthrie G, et al. The prevalence of pain among patients with chronic kidney disease using systematic review and meta-analysis. Kidney Int. 2021;100(3):636–49.
pubmed: 33940112 doi: 10.1016/j.kint.2021.03.041
Baumeister H, Kriston L, Bengel J, Härter M. High agreement of self-report and physician-diagnosed somatic conditions yields limited bias in examining mental-physical comorbidity. J Clin Epidemiol. 2010;63(5):558–65.
pubmed: 19959329 doi: 10.1016/j.jclinepi.2009.08.009
Peeters GM, Alshurafa M, Schaap L, de Vet HC. Diagnostic accuracy of self-reported arthritis in the general adult population is acceptable. J Clin Epidemiol. 2015;68(4):452–9.
pubmed: 25459981 doi: 10.1016/j.jclinepi.2014.09.019
Veronese N, Stubbs B, Solmi M, Smith TO, Reginster JY, Maggi S. Osteoarthritis increases the risk of cardiovascular disease: data from the osteoarthritis initiative. J Nutr Health Aging. 2018;22(3):371–6.
pubmed: 29484350 doi: 10.1007/s12603-017-0941-0
Rahman MM, Cibere J, Anis AH, Goldsmith CH, Kopec JA. Risk of type 2 diabetes among osteoarthritis patients in a prospective longitudinal study. Int J Rheumatol. 2014;2014: 620920.
pubmed: 25538769 pmcid: 4236891 doi: 10.1155/2014/620920

Auteurs

Xiaoxi Li (X)

Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, 230032, Anhui, China.
Inflammation and Immune Mediated Diseases, Laboratory of Anhui Province, Hefei, 230032, Anhui, China.

Feng Pan (F)

Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7000, Australia.

Rui Zhu (R)

Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, 230032, Anhui, China.
Inflammation and Immune Mediated Diseases, Laboratory of Anhui Province, Hefei, 230032, Anhui, China.

Liru Ge (L)

Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, 230032, Anhui, China.
Inflammation and Immune Mediated Diseases, Laboratory of Anhui Province, Hefei, 230032, Anhui, China.

Xiaoyue Zhang (X)

Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, 230032, Anhui, China.
Inflammation and Immune Mediated Diseases, Laboratory of Anhui Province, Hefei, 230032, Anhui, China.

Xiangrui Wen (X)

Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, 230032, Anhui, China.
Second Clinical Medical College, Anhui Medical University, Hefei, 230032, Anhui, China.

Jiantao Zhou (J)

Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, 230032, Anhui, China.
Second Clinical Medical College, Anhui Medical University, Hefei, 230032, Anhui, China.

Jiale Cheng (J)

Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, 230032, Anhui, China.
Second Clinical Medical College, Anhui Medical University, Hefei, 230032, Anhui, China.

Faming Pan (F)

Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, 230032, Anhui, China.
Inflammation and Immune Mediated Diseases, Laboratory of Anhui Province, Hefei, 230032, Anhui, China.

Guoqi Cai (G)

Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, 230032, Anhui, China. guoqi.cai@utas.edu.au.
Inflammation and Immune Mediated Diseases, Laboratory of Anhui Province, Hefei, 230032, Anhui, China. guoqi.cai@utas.edu.au.
Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7000, Australia. guoqi.cai@utas.edu.au.

Classifications MeSH